Analysis of ESR1 Mutation Spectrum from Non-Small-Cell Lung Cancer in Chinese Patients

被引:0
|
作者
Xu, C. [1 ]
Wang, W. [2 ]
Zhang, Q. [3 ]
Zhuang, W. [4 ]
Zhu, Y. [5 ]
Huang, Y. [4 ]
Chen, Y. [3 ]
Chen, G. [3 ]
Fang, M. [2 ]
Lv, T. [6 ]
Song, Y. [6 ]
机构
[1] Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[3] Fujian Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China
[4] Fujian Canc Hosp, Med Oncol, Fuzhou, Fujian, Peoples R China
[5] Zhejiang Rongjun Hosp, Jiaxing, Peoples R China
[6] Jinling Hosp, Nanjing, Jiangsu, Peoples R China
关键词
Non-small-cell lung cancer; Prognosis; ESR1; mutation;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.03-08
引用
收藏
页码:S913 / S913
页数:1
相关论文
共 50 条
  • [41] Progress of non-small-cell lung cancer with ROS1 rearrangement
    Yang, Xin
    Tang, Zhe
    Li, Jing
    Jiang, Jizong
    Liu, Yue
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [42] Chemotherapy of elderly patients with non-small-cell lung cancer
    Kloke, O
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2001, 34 (04): : 277 - 279
  • [43] Amrubicin for non-small-cell lung cancer and small-cell lung cancer
    Kurata, Takayasu
    Okamoto, Isamu
    Tamura, Kenji
    Fukuoka, Masahiro
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (05) : 499 - 504
  • [44] EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry
    Mraihi, Zohra
    Ben Amar, Jihen
    Bouacha, Hend
    Rammeh, Soumaya
    Hila, Lamia
    BMC PULMONARY MEDICINE, 2018, 18
  • [45] Amrubicin for non-small-cell lung cancer and small-cell lung cancer
    Takayasu Kurata
    Isamu Okamoto
    Kenji Tamura
    Masahiro Fukuoka
    Investigational New Drugs, 2007, 25 : 499 - 504
  • [46] EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry
    Zohra Mraihi
    Jihen Ben Amar
    Hend Bouacha
    Soumaya Rammeh
    Lamia Hila
    BMC Pulmonary Medicine, 18
  • [47] Somatic Mutations in BRCA2 Genes Are Associated with Prognosis in Chinese Non-Small-Cell Lung Cancer Patients
    Lai, J.
    Xu, C.
    Wang, W.
    Zhang, Q.
    Zhuang, W.
    Zhu, Y.
    Huang, Y.
    Chen, Y.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S522 - S522
  • [48] Analysis of the characteristics and prognosis of advanced non-small-cell lung cancer in older patients
    Gao, Ying
    Gao, Fei
    Ma, Jin-lu
    Zhang, Xiao-zhi
    Li, Yi
    Song, Li-ping
    Zhao, Dong-li
    PATIENT PREFERENCE AND ADHERENCE, 2015, 9 : 1189 - 1194
  • [49] Age and treatment of non-small-cell lung cancer: a database analysis in elderly patients
    Berghmans, T
    Tragas, G
    Sculier, JP
    SUPPORTIVE CARE IN CANCER, 2002, 10 (08) : 619 - 623
  • [50] Analysis of TET2 Gene Aberrations in East Asian Non-Small-Cell Lung Cancer Patients and Evaluation of Their Prognosis
    Zhang, Y.
    Xu, C.
    Wang, W.
    Zhang, Q.
    Zhuang, W.
    Zhu, Y.
    Huang, Z.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S432 - S432